Insider Transactions in Q2 2023 at Vyne Therapeutics Inc. (VYNE)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-1.12%
|
$364
$4.1 P/Share
|
|
Jun 30
2023
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
981
-1.84%
|
$3,924
$4.1 P/Share
|
|
Jun 30
2023
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
157
-0.61%
|
$628
$4.1 P/Share
|
|
Jun 30
2023
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
151
-1.45%
|
$604
$4.1 P/Share
|
|
May 31
2023
|
David Domzalski PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+4.92%
|
$8,298
$3.46 P/Share
|
|
May 31
2023
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
BUY
Grant, award, or other acquisition
|
Direct |
3,664
+12.39%
|
$10,992
$3.46 P/Share
|